Neuronal K+-Cl- cotransporter KCC2 as a promising drug target for epilepsy treatment
E McMoneagle, J Zhou, S Zhang, W Huang… - Acta Pharmacologica …, 2024 - nature.com
Epilepsy is a prevalent neurological disorder characterized by unprovoked seizures. γ-
Aminobutyric acid (GABA) serves as the primary fast inhibitory neurotransmitter in the brain …
Aminobutyric acid (GABA) serves as the primary fast inhibitory neurotransmitter in the brain …
Role of NKCC1 and KCC2 in epilepsy: from expression to function
R Liu, J Wang, S Liang, G Zhang, X Yang - Frontiers in neurology, 2020 - frontiersin.org
As a main inhibitory neurotransmitter in the central nervous system, γ-aminobutyric acid
(GABA) activates chloride-permeable GABAa receptors (GABAa Rs) and induces chloride …
(GABA) activates chloride-permeable GABAa receptors (GABAa Rs) and induces chloride …
Noninvasive targeted transcranial neuromodulation via focused ultrasound gated drug release from nanoemulsions
Targeted, noninvasive neuromodulation of the brain of an otherwise awake subject could
revolutionize both basic and clinical neuroscience. Toward this goal, we have developed …
revolutionize both basic and clinical neuroscience. Toward this goal, we have developed …
Brain-derived neurotrophic factor and epilepsy: a systematic review
Several in vitro, ex vivo and in vivo studies imply brain-derived neurotrophic factor (BDNF) in
the pathophysiology of epilepsy. Aim of our work is to report the most important findings …
the pathophysiology of epilepsy. Aim of our work is to report the most important findings …
[HTML][HTML] Synaptic genes and neurodevelopmental disorders: From molecular mechanisms to developmental strategies of behavioral testing
C Michetti, A Falace, F Benfenati, A Fassio - Neurobiology of Disease, 2022 - Elsevier
Synaptopathies are a class of neurodevelopmental disorders caused by modification in
genes coding for synaptic proteins. These proteins oversee the process of …
genes coding for synaptic proteins. These proteins oversee the process of …
Excitatory/inhibitory balance in epilepsies and neurodevelopmental disorders: Depolarizing γ‐aminobutyric acid as a common mechanism
EJH van van Hugte, D Schubert, N Nadif Kasri - Epilepsia, 2023 - Wiley Online Library
Epilepsy is one of the most common neurological disorders. Although many factors
contribute to epileptogenesis, seizure generation is mostly linked to hyperexcitability due to …
contribute to epileptogenesis, seizure generation is mostly linked to hyperexcitability due to …
Neonatal seizures: impact on neurodevelopmental outcomes
Neonatal period is the most vulnerable time for the occurrence of seizures, and neonatal
seizures often pose a clinical challenge both for their acute management and frequency of …
seizures often pose a clinical challenge both for their acute management and frequency of …
[HTML][HTML] Novel therapeutics for neonatal seizures
Neonatal seizures are a common neurologic emergency for which therapies have not
significantly changed in decades. Improvements in diagnosis and pathophysiologic …
significantly changed in decades. Improvements in diagnosis and pathophysiologic …
Dose-dependent reversal of KCC2 hypofunction and phenobarbital-resistant neonatal seizures by ANA12
BM Carter, BJ Sullivan, JR Landers, SD Kadam - Scientific Reports, 2018 - nature.com
Neonatal seizures have an incidence of 3.5 per 1000 newborns; while hypoxic-ischemic
encephalopathy (HIE) accounts for 50–60% of cases, half are resistant to 1st-line anti …
encephalopathy (HIE) accounts for 50–60% of cases, half are resistant to 1st-line anti …
Targeting ischemia-induced KCC2 hypofunction rescues refractory neonatal seizures and mitigates epileptogenesis in a mouse model
BJ Sullivan, PA Kipnis, BM Carter, LR Shao… - Science …, 2021 - science.org
Neonatal seizures pose a clinical challenge in their early detection, acute management, and
long-term comorbidities. They are often caused by hypoxic-ischemic encephalopathy and …
long-term comorbidities. They are often caused by hypoxic-ischemic encephalopathy and …